Generalizable Strategies for the Synthesis of Cereblon‐Recruiting PROTAC Prodrugs
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.3238473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Aiden X Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Prodrugs, Ubiquitin-Protein Ligases, Antineoplastic Agents, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, CCSG Award for the Koch Institute, Yosemite-American Cancer Society Award.
Abstract (Originalsprache)
Cereblon (CRBN)‐recruiting PROTACs (proteolysis‐targeting chimeras) are among the most clinically advanced degraders but remain challenging to chemically modify for translation to prodrug‐based delivery strategies. Here, we report three orthogonal approaches—triazole quaternization, tertiary‐amine alkylation, and installation of a hydroxyl linker—that enable chemoselective, high‐yielding syntheses of CRBN‐recruiting PROTAC prodrugs. These strategies allow incorporation of self‐immolative linkers whose cleavage kinetics can be predictably tuned to release the parent PROTAC, which is demonstrated in the context of PEGylated macromonomer and bottlebrush prodrug macromolecular scaffolds. In multiple myeloma models, representative PROTAC‐bottlebrush prodrugs (PROTAC‐BPDs) induce cellular potency profiles that follow the designed PROTAC release rates, confirming that the observed protein degradation and cytotoxicity arise from effective prodrug linker cleavage. Collectively, this work establishes generalizable approaches for constructing prodrugs of CRBN‐based PROTACs, expanding the synthetic space for targeted protein degradation and providing new design principles for controlling degrader activation, selectivity, and in vivo delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Center For Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
ORCID-Profile: Aiden X Wang, Jeremiah A Johnson
Förderung
- NCI NIH HHS
- CCSG Award for the Koch Institute
- Yosemite-American Cancer Society Award
- National Institutes of Health
Zitieren
APA
Wang, A. X., Liu, B., Ackerman, E. M., Xiang, Y., Nguyen, H. V., Jiang, Y., Koehler, A. N., & Johnson, J. A. (2026). Generalizable Strategies for the Synthesis of Cereblon‐Recruiting PROTAC Prodrugs. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.3238473
Vancouver
Wang AX, Liu B, Ackerman EM, Xiang Y, Nguyen HV, Jiang Y, et al. Generalizable Strategies for the Synthesis of Cereblon‐Recruiting PROTAC Prodrugs. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.3238473
BibTeX
@article{Wang2026,
author = {Wang, Aiden X and Liu, Bin and Ackerman, Elise M and Xiang, Yichen and Nguyen, Hung V-T and Jiang, Yivan and Koehler, Angela N and Johnson, Jeremiah A},
title = {Generalizable Strategies for the Synthesis of Cereblon‐Recruiting PROTAC Prodrugs},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.3238473}
}
EUVIMED